Unknown

Dataset Information

0

Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.


ABSTRACT:

SUBMITTER: Carden MA 

PROVIDER: S-EPMC7013265 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.

Carden Marcus A MA   Gaddh Manila M   Hoskote Abhinav A   Brown Michael M   Merrill Virginia V   Stowell Sean R SR   Chandrakasan Shanmuganathan S   Antun Ana A   Kudchadkar Ragini R   Kotanchiyev Sarah S   Jaye David L DL   Bodó Imre I  

Blood advances 20200201 3


Similar Datasets

| S-EPMC4082756 | biostudies-literature
2007-07-01 | GSE7322 | GEO
| S-EPMC9037831 | biostudies-literature
| S-EPMC6624401 | biostudies-literature
| S-EPMC11543749 | biostudies-literature
| S-EPMC2270297 | biostudies-literature
| S-EPMC6485963 | biostudies-literature
| S-EPMC9053252 | biostudies-literature